| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| MOH - MOH | HOLD | 0 @ USD 216.06 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 216.06. The average price that MOH shares were previous bought at was USD 306.545. The current market price is -29.5% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 36,349 compared to the previous valuation of MOH however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 216.06 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 216.06. The average price that MOH shares were previous bought at was USD 306.545. The current market price is -29.5% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 36,349 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 520.57 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 520.57. The average price that IDXX shares were previous bought at was USD 451.69. The current market price is 15.2% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 224,886 compared to the previous valuation of IDEXX Laboratories Inc |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 226.56 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 226.56. The average price that HUM shares were previous bought at was USD 263.605. The current market price is -14.1% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 257,092 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 226.56 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 226.56. The average price that HUM shares were previous bought at was USD 263.605. The current market price is -14.1% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 257,092 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 30.41 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 30.41. The average price that CNC shares were previous bought at was USD 59.2099. The current market price is -48.6% lower than average price they were purchased at. The value of the holding in CNC has increased by USD 92,979 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 161.11 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 161.11. The average price that CAH shares were previous bought at was USD 132.76. The current market price is 21.4% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 9,816 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| DXCM - DexCom Inc | HOLD | 0 @ USD 84.13 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 84.13. The average price that DXCM shares were previous bought at was USD 78.3581. The current market price is 7.4% higher than average price they were purchased at. The value of the holding in DXCM has fallen by USD 115,734 compared to the previous valuation of DexCom Inc |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1184.2 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1184.2. The average price that MTD shares were previous bought at was USD 1228.19. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 149,347 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1184.2 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1184.2. The average price that MTD shares were previous bought at was USD 1228.19. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 149,347 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| BIIB - Biogen Inc | HOLD | 0 @ USD 128.46 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 128.46. The average price that BIIB shares were previous bought at was USD 141.02. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in BIIB has increased by USD 64,616 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 224.38 | USD 0 | The current share valuation price of WST based on adjusted close was USD 224.38. The average price that WST shares were previous bought at was USD 251.218. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in WST has increased by USD 109,270 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 289.56 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 289.56. The average price that WAT shares were previous bought at was USD 362.82. The current market price is -20.2% lower than average price they were purchased at. USD 0 compared to the previous valuation of Waters Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 289.56 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 289.56. The average price that WAT shares were previous bought at was USD 362.82. The current market price is -20.2% lower than average price they were purchased at. USD 0 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 94.22 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 94.22. The average price that ZBH shares were previous bought at was USD 104.881. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 16,986 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 227.62 | USD 0 | The current share valuation price of STE based on adjusted close was USD 227.62. The average price that STE shares were previous bought at was USD 223.954. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 54,666 compared to the previous valuation of STERIS plc |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 72.7 | USD 0 | The current share valuation price of COO based on adjusted close was USD 72.7. The average price that COO shares were previous bought at was USD 86.8441. The current market price is -16.3% lower than average price they were purchased at. The value of the holding in COO has increased by USD 45,793 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 245.98 | USD 0 | The current share valuation price of LH based on adjusted close was USD 245.98. The average price that LH shares were previous bought at was USD 246.13. The current market price is -0.1% lower than average price they were purchased at. The value of the holding in LH has increased by USD 12,629 compared to the previous valuation of Laboratory Corporation of America Holdings however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 288.27 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 288.27. The average price that PODD shares were previous bought at was USD 277.376. The current market price is 3.9% higher than average price they were purchased at. The value of the holding in PODD has fallen by USD 55,384 compared to the previous valuation of Insulet Corporation |
| RMD - ResMed Inc | HOLD | 0 @ USD 254.25 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 254.25. The average price that RMD shares were previous bought at was USD 237.406. The current market price is 7.1% higher than average price they were purchased at. The value of the holding in RMD has increased by USD 150,987 compared to the previous valuation of ResMed Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 63.86 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 63.86. The average price that HOLX shares were previous bought at was USD 66.5861. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in HOLX has increased by USD 61,055 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 167.03 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 167.03. The average price that DGX shares were previous bought at was USD 168.441. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in DGX has increased by USD 30,942 compared to the previous valuation of Quest Diagnostics Incorporated however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 28.37 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 28.37. The average price that BAX shares were previous bought at was USD 32.4244. The current market price is -12.5% lower than average price they were purchased at. The value of the holding in BAX has increased by USD 28,320 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 190.24 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 190.24. The average price that ALGN shares were previous bought at was USD 187.06. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in ALGN has fallen by USD 80,166 compared to the previous valuation of Align Technology Inc |
| VTRS - Viatris Inc | HOLD | 0 @ USD 9.08 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 9.08. The average price that VTRS shares were previous bought at was USD 10.2249. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in VTRS has increased by USD 82,203 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 94.9 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 94.9. The average price that RVTY shares were previous bought at was USD 110.032. The current market price is -13.8% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 53,933 compared to the previous valuation of Revvity Inc. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 32.06 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 32.06. The average price that MRNA shares were previous bought at was USD 34.1169. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in MRNA has increased by USD 72,706 compared to the previous valuation of Moderna Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 69.23 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 69.23. The average price that INCY shares were previous bought at was USD 68.9686. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 72,099 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 170.28 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 170.28. The average price that UHS shares were previous bought at was USD 186.901. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in UHS has fallen by USD 174,818 compared to the previous valuation of Universal Health Services Inc |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 51.79 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 51.79. The average price that TECH shares were previous bought at was USD 62.9582. The current market price is -17.7% lower than average price they were purchased at. The value of the holding in TECH has increased by USD 26,484 compared to the previous valuation of Bio-Techne Corp however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| CRL - Creightons Plc | HOLD | 0 @ USD 154.94 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 154.94. The average price that CRL shares were previous bought at was USD 166.023. The current market price is -6.7% lower than average price they were purchased at. The value of the holding in CRL has increased by USD 11,686 compared to the previous valuation of Creightons Plc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 73.03 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 73.03. The average price that SOLV shares were previous bought at was USD 73.9165. The current market price is -1.2% lower than average price they were purchased at. The value of the holding in SOLV has fallen by USD 41,421 compared to the previous valuation of Solventum Corp. |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 69.32 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 69.32. The average price that HSIC shares were previous bought at was USD 72.5313. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in HSIC has fallen by USD 75,296 compared to the previous valuation of Henry Schein Inc |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 140.22 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 140.22. The average price that DVA shares were previous bought at was USD 152.044. The current market price is -7.8% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 5,893 compared to the previous valuation of DaVita HealthCare Partners Inc |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 109.85 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 109.85. The average price that GILD shares were previous bought at was USD 103.816. The current market price is 5.8% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 449,228 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 292.49 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 292.49. The average price that UNH shares were previous bought at was USD 495.756. The current market price is -41.0% lower than average price they were purchased at. The value of the holding in UNH has increased by USD 323,533 compared to the previous valuation of UnitedHealth Group Incorporated however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 164.78 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 164.78. The average price that JNJ shares were previous bought at was USD 156.97. The current market price is 5.0% higher than average price they were purchased at. The value of the holding in JNJ has increased by USD 10,571,480 compared to the previous valuation of Johnson & Johnson however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 190.58 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 190.58. The average price that ABBV shares were previous bought at was USD 192.168. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in ABBV has increased by USD 3,383,672 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 82.43 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 82.43. The average price that MRK shares were previous bought at was USD 90.1354. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 1,043,768 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 82.43 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 82.43. The average price that MRK shares were previous bought at was USD 90.1354. The current market price is -8.5% lower than average price they were purchased at. The value of the holding in MRK has increased by USD 1,043,768 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 416.31 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 416.31. The average price that TMO shares were previous bought at was USD 504.88. The current market price is -17.5% lower than average price they were purchased at. The value of the holding in TMO has fallen by USD 289,954 compared to the previous valuation of Time Out Group plc |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 131.74 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 131.74. The average price that ABT shares were previous bought at was USD 128.101. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in ABT has increased by USD 198,816 compared to the previous valuation of Abbott Laboratories however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 512.64 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 512.64. The average price that ISRG shares were previous bought at was USD 535.412. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in ISRG has increased by USD 67,173 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 299.02 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 299.02. The average price that AMGN shares were previous bought at was USD 300.759. The current market price is -0.6% lower than average price they were purchased at. The value of the holding in AMGN has increased by USD 1,600,158 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 193.3 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 193.3. The average price that DHR shares were previous bought at was USD 213.818. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in DHR has increased by USD 128,159 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 193.3 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 193.3. The average price that DHR shares were previous bought at was USD 213.818. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in DHR has increased by USD 128,159 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 24.61 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 24.61. The average price that PFE shares were previous bought at was USD 25.4721. The current market price is -3.4% lower than average price they were purchased at. USD 0 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 103.19 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 103.19. The average price that BSX shares were previous bought at was USD 99.2677. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 196,104 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 103.19 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 103.19. The average price that BSX shares were previous bought at was USD 99.2677. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in BSX has fallen by USD 196,104 compared to the previous valuation of MULSTRXSSXIMETFP |
| SYK - Stryker Corporation | HOLD | 0 @ USD 390.87 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 390.87. The average price that SYK shares were previous bought at was USD 378.931. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in SYK has increased by USD 44,025 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 469.55 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 469.55. The average price that VRTX shares were previous bought at was USD 472.108. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in VRTX has increased by USD 628,144 compared to the previous valuation of Vertex Pharmaceuticals Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 47.17 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 47.17. The average price that BMY shares were previous bought at was USD 55.4006. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in BMY has increased by USD 688,356 compared to the previous valuation of Bloomsbury Publishing Plc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 789.8 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 789.8. The average price that LLY shares were previous bought at was USD 829.133. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in LLY has increased by USD 6,492,802 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 89.78 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 89.78. The average price that MDT shares were previous bought at was USD 88.3291. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 328,301 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 344.55 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 344.55. The average price that ELV shares were previous bought at was USD 405.601. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 861,622 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 344.55 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 344.55. The average price that ELV shares were previous bought at was USD 405.601. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in ELV has increased by USD 861,622 compared to the previous valuation of Elevance Health Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 305.82 | USD 0 | The current share valuation price of CI based on adjusted close was USD 305.82. The average price that CI shares were previous bought at was USD 316.282. The current market price is -3.3% lower than average price they were purchased at. The value of the holding in CI has increased by USD 412,962 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 547.93 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 547.93. The average price that REGN shares were previous bought at was USD 679.66. The current market price is -19.4% lower than average price they were purchased at. The value of the holding in REGN has fallen by USD 1,424 compared to the previous valuation of Regeneron Pharmaceuticals Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 151.54 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 151.54. The average price that ZTS shares were previous bought at was USD 166.363. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in ZTS has fallen by USD 268,049 compared to the previous valuation of Zoetis Inc |
| MCK - McKesson Corporation | HOLD | 0 @ USD 715.74 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 715.74. The average price that MCK shares were previous bought at was USD 639.059. The current market price is 12.0% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 281,483 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 63.8 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 63.8. The average price that CVS shares were previous bought at was USD 63.5284. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 81,379 compared to the previous valuation of CVS Health Corp |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 178.27 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 178.27. The average price that BDX shares were previous bought at was USD 219.065. The current market price is -18.6% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 5,222 compared to the previous valuation of Becton Dickinson and Company |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 362.58 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 362.58. The average price that HCA shares were previous bought at was USD 342.952. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in HCA has fallen by USD 730,399 compared to the previous valuation of HCA Holdings Inc |
| COR - Cencora Inc. | HOLD | 0 @ USD 297.83 | USD 0 | The current share valuation price of COR based on adjusted close was USD 297.83. The average price that COR shares were previous bought at was USD 261.802. The current market price is 13.8% higher than average price they were purchased at. The value of the holding in COR has increased by USD 250,857 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 76.14 | USD 0 | The current share valuation price of EW based on adjusted close was USD 76.14. The average price that EW shares were previous bought at was USD 71.5785. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 179,316 compared to the previous valuation of Edwards Lifesciences Corp |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 113.43 | USD 0 | The current share valuation price of A based on adjusted close was USD 113.43. The average price that A shares were previous bought at was USD 126.417. The current market price is -10.3% lower than average price they were purchased at. The value of the holding in A has increased by USD 63,970 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 75.45 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 75.45. The average price that GEHC shares were previous bought at was USD 82.0681. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in GEHC has increased by USD 221,840 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 158.64 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 158.64. The average price that IQV shares were previous bought at was USD 186.439. The current market price is -14.9% lower than average price they were purchased at. The value of the holding in IQV has increased by USD 71,792 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-07-16 this would crystalise an overall loss. |